- Home
- ACET vs NIXX Comparison
ACET vs NIXX Comparison
Compare ACET & NIXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- NIXX
- Stock Information
- Founded
- ACET 1947
- NIXX 2010
- Country
- ACET United States
- NIXX United States
- Employees
- ACET N/A
- NIXX N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- NIXX
- Sector
- ACET Health Care
- NIXX
- Exchange
- ACET Nasdaq
- NIXX NYSE
- Market Cap
- ACET 83.2M
- NIXX 66.8M
- IPO Year
- ACET N/A
- NIXX N/A
- Fundamental
- Price
- ACET $0.98
- NIXX $1.96
- Analyst Decision
- ACET Buy
- NIXX
- Analyst Count
- ACET 5
- NIXX 0
- Target Price
- ACET $5.67
- NIXX N/A
- AVG Volume (30 Days)
- ACET 1.6M
- NIXX 213.0K
- Earning Date
- ACET 03-18-2025
- NIXX 04-15-2025
- Dividend Yield
- ACET N/A
- NIXX N/A
- EPS Growth
- ACET N/A
- NIXX N/A
- EPS
- ACET N/A
- NIXX N/A
- Revenue
- ACET N/A
- NIXX $668,693.00
- Revenue This Year
- ACET N/A
- NIXX $209.13
- Revenue Next Year
- ACET N/A
- NIXX N/A
- P/E Ratio
- ACET N/A
- NIXX N/A
- Revenue Growth
- ACET N/A
- NIXX N/A
- 52 Week Low
- ACET $0.81
- NIXX $1.20
- 52 Week High
- ACET $2.61
- NIXX $8.50
- Technical
- Relative Strength Index (RSI)
- ACET 57.01
- NIXX N/A
- Support Level
- ACET $0.84
- NIXX N/A
- Resistance Level
- ACET $1.04
- NIXX N/A
- Average True Range (ATR)
- ACET 0.08
- NIXX 0.00
- MACD
- ACET 0.01
- NIXX 0.00
- Stochastic Oscillator
- ACET 68.65
- NIXX 0.00
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About NIXX NIXXY INC
Nixxy Inc formerly Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.